TRPV3 and Hepatic fibrosis: Similarly, drofenine, a TRPV3 selective agonist, exacerbated liver fibrosis in a CCl4-induced mouse liver fibrosis model, while forsythoside B, a TRPV3 inhibitor, significantly mitigated liver fibrosis, although the underlying mechanism warrants further investigation [57].